ONTELRIQ Trademark

Trademark Overview

On Monday, April 29, 2013, a trademark application was filed for ONTELRIQ with the United States Patent and Trademark Office. The USPTO has given the ONTELRIQ trademark a serial number of 79129963. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Saturday, April 29, 2023. This trademark is owned by IPSEN PHARMA S.A.S. The ONTELRIQ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in oncology, endocrinology, neurology, hematology, gastroenterology, uroloty and for cardivascular and cognitive disorders
ontelriq

General Information

Serial Number79129963
Word MarkONTELRIQ
Filing DateMonday, April 29, 2013
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateSaturday, April 29, 2023
Registration Number4473154
Registration DateTuesday, January 28, 2014
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 12, 2013

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in oncology, endocrinology, neurology, hematology, gastroenterology, uroloty and for cardivascular and cognitive disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, February 26, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameIPSEN PHARMA S.A.S
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressFR
Party NameIPSEN PHARMA S.A.S
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressFR
Party NameIPSEN PHARMA S.A.S
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressFR

Trademark Events

Event DateEvent Description
Monday, November 20, 2023NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Monday, November 20, 2023DEATH OF INTERNATIONAL REGISTRATION
Sunday, March 20, 2022TOTAL INVALIDATION PROCESSED BY THE IB
Thursday, February 17, 2022TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Thursday, February 17, 2022INVALIDATION PROCESSED
Tuesday, October 26, 2021TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, February 26, 2021CANCELLED SECTION 71
Tuesday, May 19, 2020REVIEW OF CORRESPONDENCE COMPLETE - INFORMATION MADE OF RECORD
Wednesday, May 13, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, March 10, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, March 10, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 10, 2020TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, March 10, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, March 10, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 10, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 10, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, January 28, 2019COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Thursday, March 9, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, March 9, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 1, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, July 4, 2014FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, June 13, 2014FINAL DISPOSITION NOTICE SENT TO IB
Friday, June 13, 2014FINAL DISPOSITION PROCESSED
Monday, April 28, 2014FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, January 28, 2014REGISTERED-PRINCIPAL REGISTER
Tuesday, November 12, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 12, 2013PUBLISHED FOR OPPOSITION
Wednesday, October 23, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, October 7, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, September 27, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 26, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 26, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 20, 2013ASSIGNED TO LIE
Tuesday, September 17, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, July 7, 2013REFUSAL PROCESSED BY IB
Monday, June 17, 2013NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, June 17, 2013REFUSAL PROCESSED BY MPU
Saturday, June 15, 2013NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, June 14, 2013NON-FINAL ACTION WRITTEN
Thursday, June 13, 2013ASSIGNED TO EXAMINER
Tuesday, June 4, 2013APPLICATION FILING RECEIPT MAILED
Friday, May 31, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 30, 2013SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

ontelriq uroloty cardivascular cognitive disorders gastroenterology hematology preparations oncology endocrinology neurology